Dong-A ST said Friday that it has released non-clinical research results on the new drug candidate, DA-1726, in a poster session at the annual American Diabetes Association (ADA) conference.DA-1726 is a new drug under development as an oxyntomodulin analog-based obesity and diabetes treatment, which
Samsung Bioepis presented the phase 3 clinical trial results of its Soliris biosimilar, eculizumab (SB12), at the European Hematology Association 2022 (EHA2022) congress in Vienna on Friday.Soliris is a humanized monoclonal antibody produced in the NS0 cell line by recombinant DNA technology. It is
Sanofi-Aventis Korea’s labor union embarked on industrial action on Tuesday, as the wage negotiation with the management failed to narrow differences.According to the union, it has requested the management to reflect on the company’s improved sales performance last year on deciding this year’s wage
The Catholic University of Korea’s Industry-Academy Cooperation Corps. and Lucas Bio signed two patent transfer agreements on Wednesday.One of the two patent transfer agreements concerns a “composition to prevent or prevent B-cell lymphoma containing mesenchymal stem cells (MSCs) expressing IL-21, t
Immunovant, the U.S. partner of Hanall Biopharma, said it would develop additional indications for HL161 (batoclimab), an autoimmune disease treatment candidate it licensed from Hanall. Accordingly, Hanall Biopharma is expected to receive an additional milestone payment from Immunovant.In a conferen
The number of patients diagnosed with end-stage renal failure last year more than doubled compared to 2012 in Korea, a state health insurance agency said Friday.According to a report released by the National Health Insurance Service (NHIS) about end-stage renal failure treatment status from 2012 to
The European Medicines Agency (EMA) included Celltrion’s antibody treatment Regkirona (regdanvimab) in the list of critical medicines for Covid-19.EMA’s Medicines Shortages Steering Group (MSSG) adopted the list of critical drugs for the Covid-19 public health emergency on Tuesday, according to the
The number of new health startups increased two-fold in the past seven years in Korea, government data showed.The Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) released the survey results on new health industry businesses.The government has been surveying
Eutilex said it would begin clinical trials for a CAR-T treatment to treat solid cancer for the first time in Korea.The company plans to submit an investigational new drug application (IND) for its CAR-T treatment pipeline in the second half of this year and has already secured non-clinical efficacy
“Korea has reached a point where the government cannot just continue to strengthen its quarantine rules,” New KDCA Commissioner Peck Kyong-ran said on Thursday.So, the government will decide the level, considering people’s acceptability and social influence under the principle of “scientific quarant
Novartis said that the Ministry of Food and Drug Safety has approved Scemblix (Ingredient: asciminib), a treatment for adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).Semblix treats adult patients with Ph+ CML in the chronic stages who have received treatment
Yonsei University Gangnam Severance Hospital said Thursday its team has successfully performed the first t-Branch stent-graft aortic procedure on two patients for the first time in Korea.The two patients developed a thoracic, abdominal aortic aneurysm. However, it was difficult to treat with a gener
Hanmi Pharmaceutical said Wednesday that the number of its drugs under development that have won orphan drug designations (ODD) has increased to 20, breaking its own record in the Korean biopharmaceutical industry.Most recently, Hanmi received an ODD from the European Medicines Agency (EMA) for LAPS
The Ministry of Health and Welfare and the Korea Health Industry Development Institute opened a C&D (connect and develop) incubation center at the Cambridge Innovation Center (CIC) in Boston, Mass., on Wednesday (EST).The ministry and the institute set up the C&D incubation center, named Korea Bio-I
An AI-based 3D brain MRI device that helps diagnose neurodegenerative diseases won national health insurance coverage for the first time in Korea.Vuno, a medical tech startup, said Thursday that its AI-backed brain quantification device, VUNO Med-DeepBrain, obtained the Health Insurance Review and A
TiumBio, a Korean biotech company focusing on cancer and rare diseases, said it would participate in the 2022 BIO International Convention (BIO USA) to discuss partnerships with multinational drugmakers and biotech firms.BIO USA is the world’s largest biotech and pharmaceutical partnering event. Thi
List Biotherapeutics, a U.S. subsidiary of Genome & Company, said that it has started the construction of its microbiome treatment production facility in Fishers City, Ind.Established in October 2020, List Biotherapeutics plans to build a large-scale microbiome production facility in Fishers Life Sc
With the recent designation of monkeypox as a second-degree infectious disease out of a four-tier system, the medical community should set up a monitoring system to detect monkeypox cases early and secure third-generation smallpox vaccines and treatments swiftly, an expert said.In particular, he sai
The number of electric scooter accidents is rising every year, and the government should introduce a system for renting a helmet along with an electric scooter to prevent craniofacial trauma, a medical paper said.A research team at the Department of Plastic and Reconstructive Surgery of Chonnam Nati
Celltrion Pharmaceutical said it would exclusively market two diabetes treatment lineups – Nesina and Actos – it took over from Takeda Pharmaceutical. Jeil Pharmaceutical has marketed the two treatments.Celltrion has decided to end the joint sales contract at the end of this month and start direct s